Matches in Wikidata for { <http://www.wikidata.org/entity/Q91744792> ?p ?o ?g. }
- Q91744792 description "article scientifique publié en 2020" @default.
- Q91744792 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q91744792 description "im März 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91744792 description "scientific article published on 30 March 2020" @default.
- Q91744792 description "wetenschappelijk artikel" @default.
- Q91744792 description "наукова стаття, опублікована 30 березня 2020" @default.
- Q91744792 name "Similar transplant outcomes between haploidentical and unrelated donors after reduced-intensity conditioning with busulfan, fludarabine, and anti-thymocyte globulin in patients with acute leukemia or myelodysplastic syndrome" @default.
- Q91744792 name "Similar transplant outcomes between haploidentical and unrelated donors after reduced-intensity conditioning with busulfan, fludarabine, and anti-thymocyte globulin in patients with acute leukemia or myelodysplastic syndrome" @default.
- Q91744792 type Item @default.
- Q91744792 label "Similar transplant outcomes between haploidentical and unrelated donors after reduced-intensity conditioning with busulfan, fludarabine, and anti-thymocyte globulin in patients with acute leukemia or myelodysplastic syndrome" @default.
- Q91744792 label "Similar transplant outcomes between haploidentical and unrelated donors after reduced-intensity conditioning with busulfan, fludarabine, and anti-thymocyte globulin in patients with acute leukemia or myelodysplastic syndrome" @default.
- Q91744792 prefLabel "Similar transplant outcomes between haploidentical and unrelated donors after reduced-intensity conditioning with busulfan, fludarabine, and anti-thymocyte globulin in patients with acute leukemia or myelodysplastic syndrome" @default.
- Q91744792 prefLabel "Similar transplant outcomes between haploidentical and unrelated donors after reduced-intensity conditioning with busulfan, fludarabine, and anti-thymocyte globulin in patients with acute leukemia or myelodysplastic syndrome" @default.
- Q91744792 P1433 Q91744792-6A14B668-9350-41AE-9590-33965B72D9AA @default.
- Q91744792 P1476 Q91744792-EE336E14-9015-4AC3-B5DE-8F6D3F16DC41 @default.
- Q91744792 P2093 Q91744792-017C4E85-456D-4908-A5D6-F9E4BBEEBC25 @default.
- Q91744792 P2093 Q91744792-0C333819-EEB0-4873-AF42-01615E3A4D42 @default.
- Q91744792 P2093 Q91744792-0E45A46A-1F35-43F9-A8C9-2D3FAAD1FF02 @default.
- Q91744792 P2093 Q91744792-31ACD864-C69F-4DFE-B615-FF2BCF4640C0 @default.
- Q91744792 P2093 Q91744792-327DAEC5-0C9D-4AAE-AD59-800F6CDEDD53 @default.
- Q91744792 P2093 Q91744792-4DD0B198-D8E1-4B29-851D-1A30AF6810DD @default.
- Q91744792 P2093 Q91744792-52FEEAA7-A1BA-49A4-81D8-3D57985F10FD @default.
- Q91744792 P2093 Q91744792-7E553363-1A39-4AD0-A563-5D028BA684EC @default.
- Q91744792 P2093 Q91744792-9452ECC7-FAC3-4CC6-919A-3CBF8CE7CAD9 @default.
- Q91744792 P2093 Q91744792-A4F55B04-E143-46B5-B1E6-6FE4FEB4A6AD @default.
- Q91744792 P275 Q91744792-b5bc2c44-3a82-4677-87c1-a4c4f288e430 @default.
- Q91744792 P2860 Q91744792-0504C912-9516-4A8F-880C-1F7E87D7C011 @default.
- Q91744792 P2860 Q91744792-1639F6FF-DE2E-4726-8499-94F75E3151C5 @default.
- Q91744792 P2860 Q91744792-1C75274B-B452-4FE9-83EF-933B3BE1D9BC @default.
- Q91744792 P2860 Q91744792-1D7B382C-23A6-4D48-89ED-5FBA5C5C1DB7 @default.
- Q91744792 P2860 Q91744792-297A0496-1364-4032-A179-9D7D0D142F1C @default.
- Q91744792 P2860 Q91744792-2F528F10-0023-4273-AD67-3B82ACC3EC7F @default.
- Q91744792 P2860 Q91744792-31A668DD-FE63-43BF-A393-53AE61143520 @default.
- Q91744792 P2860 Q91744792-45F54577-40EE-4CFE-B007-9574679B48B2 @default.
- Q91744792 P2860 Q91744792-4A9A9CCA-E30E-49BB-B6FE-DF5BBAB7E5E8 @default.
- Q91744792 P2860 Q91744792-4FCAE033-B64E-4E8E-A130-DC53EFAC02E6 @default.
- Q91744792 P2860 Q91744792-58846032-DFC1-48E3-8EEC-F425C9F858FA @default.
- Q91744792 P2860 Q91744792-7381D067-1D32-4DFC-8E3E-F442BBA72064 @default.
- Q91744792 P2860 Q91744792-763269E1-7461-4195-BAD1-1412974933A6 @default.
- Q91744792 P2860 Q91744792-787143DF-6CC4-49EC-B860-B925BCA768C9 @default.
- Q91744792 P2860 Q91744792-8D0D455F-0E86-4D3F-B5E9-1D0DD161A83A @default.
- Q91744792 P2860 Q91744792-AFF8D678-26DB-4394-84BB-95DCC415FE62 @default.
- Q91744792 P2860 Q91744792-B4DE5502-A69E-47E9-AF92-70CA0160DA9D @default.
- Q91744792 P2860 Q91744792-C057EB24-93D9-4D75-AD91-3A4E80D3EA1F @default.
- Q91744792 P2860 Q91744792-C3CB549E-CD4B-4E0A-9001-BEB48E9531CD @default.
- Q91744792 P2860 Q91744792-C422377C-99CA-4E3D-8EF7-69144771B641 @default.
- Q91744792 P2860 Q91744792-C6747361-EAE2-41BC-8267-4100E08B26CB @default.
- Q91744792 P2860 Q91744792-D018BA40-A556-4B07-94B9-7E85C87C8F9F @default.
- Q91744792 P2860 Q91744792-E2E4E810-941A-4C13-8818-A7FA9DDE64BE @default.
- Q91744792 P2860 Q91744792-E6792DE0-C68B-42D2-9074-413320483954 @default.
- Q91744792 P2860 Q91744792-EFBA5CFB-1F2E-43DB-A649-0B75E6B5A0F2 @default.
- Q91744792 P2860 Q91744792-FB65324A-2C26-465F-AB30-1C1C5DE2FF8A @default.
- Q91744792 P304 Q91744792-239C5358-0F71-4A08-BE8E-20703FF2C9DB @default.
- Q91744792 P31 Q91744792-EEA6A9EF-DCC5-40F8-8D2A-A4510ADC6D67 @default.
- Q91744792 P356 Q91744792-E8734B84-E529-49D7-A3E2-9923CECC2F8F @default.
- Q91744792 P433 Q91744792-42954414-E231-4313-AB86-8435A9C58DBC @default.
- Q91744792 P478 Q91744792-7B5A8BCC-AE87-4FA6-B8AB-06BFD1B2A98A @default.
- Q91744792 P577 Q91744792-D8F5488B-39DC-4CD3-ABE3-DDCBDB50EE8A @default.
- Q91744792 P6216 Q91744792-59c0351a-601f-483c-b571-1b7aa0f9ecd1 @default.
- Q91744792 P698 Q91744792-826F052F-C633-4737-BE38-0CA21427BBD9 @default.
- Q91744792 P921 Q91744792-427CFDBD-72A1-42D3-9C3E-D6CF66102C83 @default.
- Q91744792 P921 Q91744792-765169FE-0D85-4D2D-BE3D-4424D5AC3137 @default.
- Q91744792 P921 Q91744792-922973B9-3B2C-4AD5-AAA7-7B78CAE1CDF5 @default.
- Q91744792 P932 Q91744792-E9A21882-A949-4F17-BA6A-D84E090C0FDA @default.
- Q91744792 P356 BR.2020.55.1.27 @default.
- Q91744792 P698 32269972 @default.
- Q91744792 P1433 Q26842305 @default.
- Q91744792 P1476 "Similar transplant outcomes between haploidentical and unrelated donors after reduced-intensity conditioning with busulfan, fludarabine, and anti-thymocyte globulin in patients with acute leukemia or myelodysplastic syndrome" @default.
- Q91744792 P2093 "Dong-Yeop Shin" @default.
- Q91744792 P2093 "Inho Kim" @default.
- Q91744792 P2093 "Ja Yoon Heo" @default.
- Q91744792 P2093 "Jeong-Ok Lee" @default.
- Q91744792 P2093 "Ji Yun Lee" @default.
- Q91744792 P2093 "Junshik Hong" @default.
- Q91744792 P2093 "Mihong Choi" @default.
- Q91744792 P2093 "Soo-Mee Bang" @default.
- Q91744792 P2093 "Sung-Soo Yoon" @default.
- Q91744792 P2093 "Youngil Koh" @default.
- Q91744792 P275 Q34179348 @default.
- Q91744792 P2860 Q24685958 @default.
- Q91744792 P2860 Q33718837 @default.
- Q91744792 P2860 Q33786536 @default.
- Q91744792 P2860 Q34398411 @default.
- Q91744792 P2860 Q34474243 @default.
- Q91744792 P2860 Q35103562 @default.
- Q91744792 P2860 Q35583434 @default.
- Q91744792 P2860 Q36461248 @default.
- Q91744792 P2860 Q37304130 @default.
- Q91744792 P2860 Q37595693 @default.
- Q91744792 P2860 Q38259420 @default.
- Q91744792 P2860 Q39837770 @default.
- Q91744792 P2860 Q40182546 @default.
- Q91744792 P2860 Q40291317 @default.
- Q91744792 P2860 Q43477032 @default.
- Q91744792 P2860 Q43519981 @default.
- Q91744792 P2860 Q44216272 @default.
- Q91744792 P2860 Q45278122 @default.
- Q91744792 P2860 Q47558022 @default.
- Q91744792 P2860 Q56525543 @default.
- Q91744792 P2860 Q59281229 @default.